دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Comparative analysis of percutaneous revascularization practice in the United States and the United Kingdom: Insights from the BMC2 and BCIS databases
Brett L. Wanamaker MD, Ahmad Shoaib MD, Milan Seth MS, Devraj Sukul MD, MS, Mamas A. Mamas DPhil, Hitinder S. Gurm MD
doi : 10.1002/ccd.30567
International registry comparisons provide insight into regional differences in clinical practice patterns, procedural outcomes, and general trends in population health and resource utilization in percutaneous coronary intervention (PCI). We sought to compare data from a state-wide PCI registry in the United States with a national registry from the United Kingdom (UK).
Long-term follow-up of contemporary drug-eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial
Nicole D. van Hemert MD, Michiel Voskuil MD, PhD, Rik Rozemeijer PharmD, MD, PhD, Adriaan O. Kraaijeveld MD, PhD, Saskia Z. Rittersma MD, PhD, Geert E. H. Leenders MD, PhD, Mèra Stein MD, PhD, Peter Frambach MD, Pim van der Harst MD, PhD, Pierfrancesco Agostoni MD, PhD, Pieter R. Stella MD, PhD, The ReCre8 Study Investigators
doi : 10.1002/ccd.30545
The elevated risk of adverse events following percutaneous coronary intervention in diabetic patients persists with newer-generation DES. The polymer-free amphilimus-eluting stent (PF-AES) possesses characteristics with a potentially enhanced performance in patients with diabetes.
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease
Huazhen Chen MD, Alessandro Spirito MD, Samantha Sartori PhD, Johny Nicolas MD, Davide Cao MD, Zhongjie Zhang MPH, Usman Baber MD, Karim Kamaleldin MD, Jeffers Guthrie AB, Birgit Vogel MD, Joseph Sweeny MD, Prakash Krishnan MD, Samin K. Sharma MD, Annapoorna Kini MD, George Dangas MD, PhD, Roxana Mehran MD
doi : 10.1002/ccd.30569
Patients with chronic kidney disease (CKD) are at higher risk of ischemic and bleeding events after percutaneous coronary intervention (PCI). Complex PCI (CPCI) is associated with higher rates of ischemic complications. Whether CPCI confers an additive risk of adverse events in CKD patients is unclear.
Efficacy of a new generation intracoronary optical coherence tomography imaging system with fast pullback
Takeshi Nishi MD, PhD, Teruyoshi Kume MD, PhD, Ryotaro Yamada MD, PhD, Satsohi Koto MD, Yoshitaka Sasahira MD, Hiroshi Okamoto MD, PhD, Tomoko Tamada MD, Terumasa Koyama MD, PhD, Koichiro Imai MD, PhD, Yoji Neishi MD, PhD, Giovanni J. Ughi PhD, Shiro Uemura MD, PhD
doi : 10.1002/ccd.30573
We sought to investigate whether a novel, fast-pullback, high-frequency optical coherence tomography (HF-OCT) imaging system enables data acquisition with a reduced amount of contrast agents while retaining the same qualitative and quantitative lesion assessment to conventional OCT.
Success rate and influencing factors of a balloon-push technique: A new technique to remove side branch-jailed struts under three-dimensional optical coherence tomography guidance
Ryoji Nagoshi MD, PhD, Yoichi Kijima MD, Amane Kozuki MD, PhD, Ryudo Fujiwara MD, PhD, Hiroyuki Shibata MD, Atsushi Suzuki MD, PhD, Fumitaka Soga MD, PhD, Hiroyuki Asada MD, Kotaro Higuchi MD, Junya Shite MD, PhD
doi : 10.1002/ccd.30548
Kissing balloon inflation with distal guide wire recross can cause severe stent deformation depending on the stent link location with respect to the carina. The balloon-push technique, by which an inflated balloon is forced into the SB from the proximal main vessel (MV), is a feasible way to remove jailed struts without causing severe stent deformation.
Validation of the new PROGRESS-CTO complication risk scores in the OPEN-CTO registry
Lorenzo Azzalini MD, PhD, MSc, Taishi Hirai MD, Adam Salisbury MD, MSc, Kensey Gosch MS, James Sapontis MBBCh, William J. Nicholson MD, Dimitri Karmpaliotis MD, PhD, Jeffrey W. Moses MD, Kathleen E. Kearney MD, William L. Lombardi MD, James Aaron Grantham MD
doi : 10.1002/ccd.30563
Risk stratification before chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is important to inform procedural planning as well as patients and their families. We sought to externally validate the PROGRESS-CTO complication risk scores in the OPEN-CTO registry.
Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry
Judit Karacsonyi MD, PhD, Khaldoon Alaswad MD, Oleg Krestyaninov MD, Dimitri Karmpaliotis MD, PhD, Ajay Kirtane MD, Ziad Ali MD, Margaret McEntegart MD, Amirali Masoumi MD, Paul Poomipanit MD, Farouc A. Jaffer MD, PhD, Jaikirshan Khatri MD, James Choi MD, Mitul Patel MD, Michalis Koutouzis MD, Ioannis Tsiafoutis MD, Sevket Gorgulu MD, Abdul M. Sheikh MD, Basem Elbarouni MD, Wissam Jaber MD, Ahmed ElGuindy MD, MSc, FRCP, Robert Yeh MD, Spyridon Kostantinis MD, Bahadir Simsek MD, Bavana Rangan BDS, MPH, Olga C. Mastrodemos BA, Evangelia Vemmou MD, Ilias Nikolakopoulos MD, Imre Ungi MD, PhD, Nidal A. Rafeh MD, Omer Goktekin MD, M. Nicholas Burke MD, Emmanouil S. Brilakis MD, PhD, Yader Sandoval MD
doi : 10.1002/ccd.30564
There is limited data on the impact of a second attending operator on chronic total occlusion (CTO) percutaneous coronary intervention (PCI) outcomes.
Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial
Sandeep Arunothayaraj MBBS, Jens Flensted Lassen PhD, Gerald J. Clesham PhD, Mark S. Spence MD, René Koning MD, Adrian P. Banning MD, Mitchell Lindsay MD, Evald H. Christiansen PhD, Mohaned Egred MD, James Cockburn MD, Darren Mylotte PhD, Philippe Brunel MD, Miroslaw Ferenc PhD, Thomas Hovasse MD, Adrian Wlodarczak PhD, Manuel Pan PhD, Marc Silvestri MD, Andrejs Erglis PhD, Evgeny Kretov MD, Alaide Chieffo MD, Thierry Lefèvre MD, Francesco Burzotta PhD, Olivier Darremont MD, Goran Stankovic PhD, Marie-Claude Morice MD, Yves Louvard MD, David Hildick-Smith MD … See fewer authors
doi : 10.1002/ccd.30575
Techniques for provisional and dual-stent left main bifurcation stenting require optimization.
Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention
Lorenzo Azzalini MD, PhD, MSc, Nicolas Boudou MD, Alexandre Avran MD, Jesse Kane MD, William L. Lombardi MD, Kathleen E. Kearney MD, Mauro Carlino MD
doi : 10.1002/ccd.30565
There is scarce data on the outcomes of the Carlino technique for chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We aimed to investigate the indications and outcomes of the Carlino technique as performed in the context of the retrograde approach.
Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk:Â Single center experience of a novel concept
Alma Räsänen MD, Jussi M. Kärkkäinen MD, PhD, Antti Eranti MD, PhD, Jaakko Eränen MD, Tuomas T. Rissanen MD, PhD
doi : 10.1002/ccd.30558
At least 1 month of dual antiplatelet therapy is required after coronary stenting. The aim of this all-comers retrospective registry study was to assess the efficacy and safety of percutaneous coronary intervention (PCI) using drug-coated balloon (DCB) with single antiplatelet treatment (SAPT).
Effect of randomized prophylactic nitroglycerin on radial artery spasm during transradial catheterization: An analysis based on operator experience
Roberto L. da Silva MD, PhD, George D. Dangas MD, PhD, Pedro B de Andrade MD, PhD, Rodrigo M. Joaquim MD, Thais R. W. da Silva MD, MSc, Tammuz Fattah MD, MSc, Vanderlei C. Pereira Jr, MD, Ricardo A. Zanella MD, Amanda G. M. Sousa MD, PhD, Fausto Feres MD, PhD, José R. Costa Jr, MD, PhD
doi : 10.1002/ccd.30541
One limitation to transradial access (TRA) is the occurrence of spasms (RAS), for which the use of prophylactic medications is recommended. Improvement in TRA material combined with the increase in operators' expertise, might mitigate this benefit.
Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion
Yota Kawamura MD, PhD, Fuminobu Yoshimachi MD, PhD, Satoshi Kasai MD, Yuji Ikari MD, PhD
doi : 10.1002/ccd.30568
Traditionally, two bigger-sized guiding catheters (GCs) via the femoral artery have been used in percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). However, those GCs are associated with an increased incidence of bleeding.
Suicide left ventricle following protamine: A case report
Saliha Erdem MD, Sin Yeong An MD, Courtney A. McAlister RN, BSN, Sukhdeep S. Basra MD
doi : 10.1002/ccd.30528
A patient with severe aortic stenosis and left ventricular hypertrophy underwent a transcatheter aortic valve replacement. The patient's blood pressure significantly dropped after protamine administration.
Society of thoracic surgeons risk score and left atrial pressure for predicting clinical outcomes among transcatheter mitral edge-to-edge repair patients
Sharon Shalom Natanzon, Keita Koseki, Danon Kaewkes, Ofir Koren, Vivek Patel, Alon Shechter, Alexander Fardman, Mamoo Nakamura, Tarun Chakravarty, Raj Makkar
doi : 10.1002/ccd.30552
Limited data exist regarding the performance of the Society of Thoracic Surgeons (STS) risk score among transcatheter mitral edge-to-edge repair (TEER) patients.
The impact of baseline transmitral diastolic mean gradient on left atrial pressure reduction in patients undergoing transcatheter mitral valve edge-to-edge repair
Nahyr Lugo-Fagundo MD, Keniel Pierre MD, Demilade Adedinsewo MB, ChB, MPH, Trevor Simard MD, Mohamad Alkhouli MD, Mackram F. Eleid MD, Charanjit S. Rihal MD, Mayra Guerrero MD, Abdallah El Sabbagh MD
doi : 10.1002/ccd.30577
Elevated transmitral gradient post transcatheter mitral valve edge-to-edge repair (TEER) has been associated with worse outcomes. Whether an elevated baseline transmitral diastolic mean gradient (MG) ≥5 mmHg is associated with hemodynamic outcomes after TEER is unknown.
Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registry
Thomas Fink MD, Christina Paitazoglou MD, Martin W. Bergmann MD, Makoto Sano MD, PhD, Ahmad Keelani MD, Vanessa Sciacca MD, Mohammed Saad MD, Charlotte Eitel MD, Christian-Hendrik Heeger MD, Carsten Skurk MD, Ulf Landmesser MD, Holger Thiele MD, Thomas Stiermaier MD, Georg Fuernau MD, Jan-Christian Reil MD, Norbert Frey MD, Karl-Heinz Kuck MD, Roland R. Tilz MD, Marcus Sandri MD, Ingo Eitel MD
doi : 10.1002/ccd.30559
Left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation (AF). OAC treatment has been proven feasible in mild-to-moderate chronic kidney disease (CKD).
Transcatheter closure of large postinfarct ventricular septal defect: Initial results of prototype Occlutech® device including the first-in-human
Kuo Ting Lee MRCP, Demetris Taliotis MD, Mark Hamilton FRCR, Nathan Manghat FRCR, MD, Radwa Bedair FRCP, Mark Turner PhD, FRCP
doi : 10.1002/ccd.30571
Postinfarct ventricular septal rupture is a serious complication in delayed or failed reperfusion with a grim prognosis. The optimal timing and treatment option remain debatable in the absence of randomized controlled trials.
Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease
Hector A. Alvarez-Covarrubias MD, Michael Joner MD, Salvatore Cassese MD, PhD, Mairead Warmbrunn MD, Jannik Lutz MD, Teresa Trenkwalder MD, Masaru Seguchi MD, Alp Aytekin MD, Antonia Presch MD, Constanza Pellegrini MD, Tobias Rheude MD, N. Patrick Mayr MD, Sebastian Kufner MD, Heribert Schunkert MD, Adnan Kastrati MD, Erion Xhepa MD, PhD
doi : 10.1002/ccd.30576
To investigate the feasibility and safety of percutaneous transluminal angioplasty (PTA) of the iliofemoral arteries (IFA) before transfemoral transcatheter aortic valve implantation (Tf-TAVI) in patients with advanced peripheral artery disease (PAD).
Cusp-overlap versus coplanar view in transcatheter aortic valve implantation with self-expandable valves: A meta-analysis of comparative studies
Michel Pompeu Sá MD, MSc, MHBA, PhD, Jef Van den Eynde BSc, Xander Jacquemyn BSc, Ozgun Erten MD, Aleksander Dokollari MD, PhD, Serge Sicouri MD, Basel Ramlawi MD, FRCSC, FACS
doi : 10.1002/ccd.30562
Permanent pacemaker implantation (PPI) is a common complication after transcatheter aortic valve implantation (TAVI). The cusp-overlap view (COV) was adopted to reduce PPI risk after TAVI with self-expandable valves (SEVs); however, the evidence remains scarce.
Percutaneous treatment of multiple fistulas associated with a giant aneurysm
Silvio Vera-Vera MD, Alfonso Jurado-Roman MD, PhD, Raúl Moreno MD, PhD, Guillermo Galeote MD, PhD
doi : 10.1002/ccd.30570
Coronary fistulas are not common in patients undergo coronary angiography. It is described, even less frequently, that coronary fistulas may be associated with giant aneurysms along their course.
Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve
Nicholas J. Montarello MBBS, Angelo Quagliana MD, PhD, Lars Søndergaard MD, PhD, Ole De Backer MD, PhD
doi : 10.1002/ccd.30561
Valve-in-valve transcatheter aortic valve replacement (VIV-TAVR) for a degenerated surgical aortic bioprosthesis is a well-established treatment modality but carries an increased risk of coronary artery obstruction (CAO) with potentially catastrophic consequences.
A very rare vascular complication of the Edwards expandable eSheath during transcatheter aortic valve replacement
Panagiotis Savvoulidis MD, PhD, Adnan M. Nadir MD, MRCP, Anthony Mechery MBBS, DM, MRCP, Sagar N. Doshi MD, BSc, Hons, MBChB, FRCP
doi : 10.1002/ccd.30557
Transcatheter aortic valve replacement (TAVR) has revolutionized the management of severe symptomatic aortic valve stenosis. TAVR is now indicated as an alternative to surgical replacement in a wide risk profile ranging from high to low surgical risk.
Transcatheter aortic valve replacement-related aortic dissection: A clinical case series
Takashi Hiruma MD, Ryosuke Higuchi MD, Mike Saji MD, PhD, Itaru Takamisawa MD, Tomoki Shimokawa MD, PhD, Mamoru Nanasato MD, PhD
doi : 10.1002/ccd.30574
We review our experience with 13 periprocedural aortic dissection (AD) cases caused by transcatheter aortic valve replacement (TAVR).
SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 Registry
Gregory Serrao MD, FSCAI, George Dangas MD, MSCAI
doi : 10.1002/ccd.30566
High bleeding risk patients
Giuseppe Tarantini MD, PhD, Francesco Cardaioli MD
doi : 10.1002/ccd.30572
